Risk of Adverse Oncological Outcomes (Residual or Recurrent Cancer) After ESD for Early-Stage Gastrointestinal Cancers: A Retrospective Cohort Study

Authors

Eitan Scheinthal, Advocate Health - MidwestFollow
Naaz Khan
Wesley N. Vu
Caitlyn Spencer, Advocate Health - MidwestFollow
Sarah Clark, Advocate Health - MidwestFollow
Mohammed Qadeer, Advocate Health - MidwestFollow

Recommended Citation

Scheinthal E, Khan N, Vu WN, Spencer C, Clark S, Qadeer M. Risk of Adverse Oncological Outcomes (Residual or Recurrent Cancer) After ESD for Early-Stage Gastrointestinal Cancers: A Retrospective Cohort Study. Poster presented at DDW (Digestive Disease Week) 2025; May 5, 2025; San Diego, CA.

Affiliations

Aurora Health Care

Aurora Medical Center Kenosha

Presentation Notes

Poster presented at DDW (Digestive Disease Week) 2025; May 5, 2025; San Diego, CA.

Type

Poster